Indium Chloride
drug drugOn this page
Also known as SID17388973SID124889857SID124889858SID144214028SID144204550
Summary
Indium Chloride (CHEMBL1447815) is an approved small molecule.
At a glance
- Status: Approved (max clinical phase 4)
- Modality: Small molecule
Identifiers
Drug identity and classification
| Field | Value |
|---|---|
| ChEMBL ID | CHEMBL1447815 |
| Name | Indium Chloride |
| Type | Small molecule |
| Max phase | 4 |
Also known as: SID17388973, SID124889857, SID124889858, SID144214028, SID144204550
Parent form; salt/anhydrous children: CHEMBL1201078, CHEMBL3187636
Targets
Targets
Broader ChEMBL bioactivity targets: 5 (assay-derived). Sample: Tyrosyl-DNA phosphodiesterase 1, 4’-phosphopantetheinyl transferase ffp, Polyunsaturated fatty acid lipoxygenase ALOX15, Mitogen-activated protein kinase 1, Lethal factor.
Bioactivity
ChEMBL activities: 2 potent at pChembl ≥ 5 of 5 total. Top 100 by potency (10 = 0.1 nM, 6 = 1 µM):
| Target | pChembl | Type | Value | Unit | Activity ID |
|---|---|---|---|---|---|
| MAPK1 | 7.4 | Potency | 39.8 | nM | CHEMBL_ACT_4545359 |
| TDP1 | 6.3 | Potency | 501.2 | nM | CHEMBL_ACT_3952124 |
Target pathways
No target-pathway data for this drug (no mapped target genes).
Indications & clinical
Indications
0 indication records carry no mapped disease name (EFO/MeSH-only); none shown.
Clinical trials
Total trials: 0.
Clinical evidence (CIViC)
No CIViC predictive evidence (expected for non-precision-medicine drugs).
Pharmacology
Pharmacogenomics
No PharmGKB pharmacogenomic data curated for this drug.
Related molecules
Related molecules
No competitor molecules sharing a primary target (ChEMBL phase ≥2 or PubChem drug-class).
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.